Drugs / MTC896
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT02293018 | Aug 2014 → Jan 2015 | acne | Mimetica Pty Limited | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT02395549 | Apr 2015 → Jun 2016 | acne | Mimetica Pty Limited | Unknown | No outcome recorded |
| Phase 2 | NCT01254162 | Jul 2010 → Jun 2011 | — | Mimetica Pty Limited | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MTC896 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01254162 ↗ |
| Route | Topical | “topically applied 0.75% (w/w) MTC896 Gel” NCT01254162 ↗ |